{"id":"https://openalex.org/W2008337869","doi":"https://doi.org/10.1111/j.1463-1326.2009.01074.x","title":"Impact of glucagon\u2010like peptide\u20101 on endothelial function","display_name":"Impact of glucagon\u2010like peptide\u20101 on endothelial function","alternate_titles":[],"publication_year":2009,"publication_date":"2009-10-29","ids":{"openalex":"https://openalex.org/W2008337869","doi":"https://doi.org/10.1111/j.1463-1326.2009.01074.x","mag":"2008337869","pmid":"https://pubmed.ncbi.nlm.nih.gov/19878258"},"language":"en","primary_location":{"id":"doi:10.1111/j.1463-1326.2009.01074.x","doi":"https://doi.org/10.1111/j.1463-1326.2009.01074.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1463-1326.2009.01074.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1463-1326.2009.01074.x","source":{"id":"https://openalex.org/S148394532","display_name":"Diabetes Obesity and Metabolism","issn_l":"1462-8902","issn":["1462-8902","1463-1326"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, Obesity and Metabolism","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2008337869"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1463-1326.2009.01074.x","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5071915626","display_name":"\u00c5ke Sj\u00f6holm","orcid":"https://orcid.org/0000-0002-5274-9748","observed_orcids":["https://orcid.org/0000-0002-5274-9748"]},"institutions":[{"id":"https://openalex.org/I28166907","display_name":"Karolinska Institutet","ror":"https://ror.org/056d84691","country_code":"SE","type":"education","lineage":["https://openalex.org/I28166907"]},{"id":"https://openalex.org/I4210094988","display_name":"Stockholm South General Hospital","ror":"https://ror.org/00ncfk576","country_code":"SE","type":"healthcare","lineage":["https://openalex.org/I4210094988"]}],"countries":["SE"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"\u00c5 Sj\u00f6holm","raw_affiliation_strings":["Department of Clinical Science, Division of Internal Medicine, Unit for Diabetes Research, Karolinska Institutet, Stockholm, Sweden. ake.sjoholm@sodersjukhuset.se","Department of Clinical Science and Education, Division of Internal Medicine, Unit for Diabetes Research, Karolinska Institutet, Stockholm, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Science, Division of Internal Medicine, Unit for Diabetes Research, Karolinska Institutet, Stockholm, Sweden. ake.sjoholm@sodersjukhuset.se","institution_ids":["https://openalex.org/I28166907","https://openalex.org/I4210094988"]},{"raw_affiliation_string":"Department of Clinical Science and Education, Division of Internal Medicine, Unit for Diabetes Research, Karolinska Institutet, Stockholm, Sweden","institution_ids":["https://openalex.org/I28166907"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5071915626"],"corresponding_institution_ids":["https://openalex.org/I28166907","https://openalex.org/I4210094988"],"apc_list":{"value":5380,"currency":"USD","value_usd":5380},"apc_paid":null,"fwci":0.1441,"has_fulltext":true,"cited_by_count":22,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.11164057,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":98},"biblio":{"volume":"11","issue":"s3","first_page":"19","last_page":"25"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10155","display_name":"Nitric Oxide and Endothelin Effects","score":0.0010000000474974513,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10027","display_name":"Diabetes, Cardiovascular Risks, and Lipoproteins","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/glucagon-like-peptide-1","display_name":"glucagon-like peptide-1","score":1.0},{"id":"https://openalex.org/keywords/endothelial-function","display_name":"endothelial function","score":0.9810000061988831},{"id":"https://openalex.org/keywords/endothelial-dysfunction","display_name":"endothelial dysfunction","score":0.8149999976158142},{"id":"https://openalex.org/keywords/glp-1-receptor-agonists","display_name":"GLP-1 receptor agonists","score":0.9259999990463257},{"id":"https://openalex.org/keywords/glp-1-receptor-antagonists","display_name":"GLP-1 receptor antagonists","score":0.9430000185966492},{"id":"https://openalex.org/keywords/incretin-hormones","display_name":"incretins","score":0.7409999966621399},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9309999942779541},{"id":"https://openalex.org/keywords/cardiovascular-disease","display_name":"cardiovascular disease","score":0.8320000171661377},{"id":"https://openalex.org/keywords/hyperglycemia","display_name":"hyperglycemia","score":0.9610000252723694},{"id":"https://openalex.org/keywords/insulin-secretion","display_name":"insulin secretion","score":0.5789999961853027},{"id":"https://openalex.org/keywords/beta-cell-dysfunction","display_name":"beta-cell dysfunction","score":0.7940000295639038},{"id":"https://openalex.org/keywords/cardiovascular-risk","display_name":"cardiovascular risk","score":0.5669999718666077}],"concepts":[{"id":"https://openalex.org/C2778881409","wikidata":"https://www.wikidata.org/wiki/Q1420402","display_name":"Incretin","level":4,"score":0.9443631172180176},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.6787562966346741},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6513451337814331},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.6481364965438843},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.6294358968734741},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.619278609752655},{"id":"https://openalex.org/C2777391703","wikidata":"https://www.wikidata.org/wiki/Q1053470","display_name":"Insulin resistance","level":3,"score":0.5850319266319275},{"id":"https://openalex.org/C2776398474","wikidata":"https://www.wikidata.org/wiki/Q424611","display_name":"Glucagon-like peptide-1","level":4,"score":0.5299694538116455},{"id":"https://openalex.org/C3020479747","wikidata":"https://www.wikidata.org/wiki/Q1029907","display_name":"Gastric emptying","level":3,"score":0.5154576897621155},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.48489242792129517},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.4736004173755646},{"id":"https://openalex.org/C185280430","wikidata":"https://www.wikidata.org/wiki/Q14909910","display_name":"Glucagon-like peptide 1 receptor","level":4,"score":0.46112579107284546},{"id":"https://openalex.org/C2780972559","wikidata":"https://www.wikidata.org/wiki/Q550061","display_name":"Endothelial dysfunction","level":2,"score":0.4306184649467468},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.4248451590538025},{"id":"https://openalex.org/C71315377","wikidata":"https://www.wikidata.org/wiki/Q11364","display_name":"Hormone","level":2,"score":0.41866442561149597},{"id":"https://openalex.org/C2779422922","wikidata":"https://www.wikidata.org/wiki/Q1029907","display_name":"Stomach","level":2,"score":0.07867559790611267},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.07615876197814941}],"mesh":[{"descriptor_ui":"D002318","descriptor_name":"Cardiovascular Diseases","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D002318","descriptor_name":"Cardiovascular Diseases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D002318","descriptor_name":"Cardiovascular Diseases","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D003925","descriptor_name":"Diabetic Angiopathies","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003925","descriptor_name":"Diabetic Angiopathies","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D003925","descriptor_name":"Diabetic Angiopathies","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D004730","descriptor_name":"Endothelium, Vascular","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D015431","descriptor_name":"Weight Loss","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D052216","descriptor_name":"Glucagon-Like Peptide 1","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D054795","descriptor_name":"Incretins","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1111/j.1463-1326.2009.01074.x","doi":"https://doi.org/10.1111/j.1463-1326.2009.01074.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1463-1326.2009.01074.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1463-1326.2009.01074.x","source":{"id":"https://openalex.org/S148394532","display_name":"Diabetes Obesity and Metabolism","issn_l":"1462-8902","issn":["1462-8902","1463-1326"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, Obesity and Metabolism","raw_type":"journal-article"},{"id":"pmid:19878258","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19878258","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, obesity & metabolism","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1111/j.1463-1326.2009.01074.x","doi":"https://doi.org/10.1111/j.1463-1326.2009.01074.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1463-1326.2009.01074.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1463-1326.2009.01074.x","source":{"id":"https://openalex.org/S148394532","display_name":"Diabetes Obesity and Metabolism","issn_l":"1462-8902","issn":["1462-8902","1463-1326"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, Obesity and Metabolism","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2008337869.pdf","grobid_xml":"https://content.openalex.org/works/W2008337869.grobid-xml"},"referenced_works_count":45,"referenced_works":["https://openalex.org/W22189248","https://openalex.org/W60947372","https://openalex.org/W1963542379","https://openalex.org/W1965806496","https://openalex.org/W1968315455","https://openalex.org/W1969759659","https://openalex.org/W1969932276","https://openalex.org/W1975756049","https://openalex.org/W1992966015","https://openalex.org/W2000976083","https://openalex.org/W2004977380","https://openalex.org/W2005230361","https://openalex.org/W2012506661","https://openalex.org/W2022101780","https://openalex.org/W2032322539","https://openalex.org/W2043869817","https://openalex.org/W2057651652","https://openalex.org/W2067710447","https://openalex.org/W2071202016","https://openalex.org/W2071835038","https://openalex.org/W2072935519","https://openalex.org/W2096716906","https://openalex.org/W2098459806","https://openalex.org/W2103525547","https://openalex.org/W2106036385","https://openalex.org/W2121497054","https://openalex.org/W2129730863","https://openalex.org/W2134141467","https://openalex.org/W2137352234","https://openalex.org/W2137408480","https://openalex.org/W2138290933","https://openalex.org/W2143014102","https://openalex.org/W2146333376","https://openalex.org/W2157677292","https://openalex.org/W2159205789","https://openalex.org/W2160001758","https://openalex.org/W2164169548","https://openalex.org/W2169562373","https://openalex.org/W2169976140","https://openalex.org/W2170606300","https://openalex.org/W2471605942","https://openalex.org/W2474156560","https://openalex.org/W2599408064","https://openalex.org/W3198570063","https://openalex.org/W4247067928"],"related_works":["https://openalex.org/W1922719710","https://openalex.org/W2129730863","https://openalex.org/W2033746319","https://openalex.org/W2057768222","https://openalex.org/W2123516651","https://openalex.org/W2385589550","https://openalex.org/W4414148479","https://openalex.org/W2394124124","https://openalex.org/W2102467882","https://openalex.org/W2161564579"],"abstract_inverted_index":{"Cardiovascular":[0],"(CV)":[1],"disease":[2],"is":[3],"the":[4,52,83,92,99,110,127,135,166],"major":[5,167],"cause":[6],"of":[7,22,37,55,63,68,103,137],"mortality":[8],"and":[9,31,40,60,66,77,126,139,146],"morbidity":[10],"in":[11,73,155],"individuals":[12],"with":[13,16,173],"diabetes.":[14,174],"Individuals":[15],"diabetes":[17],"often":[18],"have":[19,120],"a":[20],"variety":[21],"factors":[23],"such":[24,46,86],"as":[25,47,87,107,109],"hyperglycaemia,":[26],"dyslipidaemia,":[27],"hypertension,":[28],"insulin":[29],"resistance":[30],"obesity,":[32],"which":[33,71],"increase":[34],"their":[35],"risks":[36,169],"endothelial":[38,124],"dysfunction":[39,97],"CV":[41,128,168],"disease.":[42],"The":[43],"incretin":[44,84],"hormones,":[45],"glucagon-like":[48],"peptide-1":[49],"(GLP-1),":[50],"induce":[51,61],"glucose-dependent":[53],"secretion":[54],"insulin,":[56],"improve":[57],"beta-cell":[58,96],"function":[59,125],"slowing":[62],"gastric":[64],"emptying":[65],"feelings":[67],"satiety":[69],"-":[70],"result":[72],"reduced":[74],"food":[75],"intake":[76],"weight":[78],"loss.":[79],"Therapeutic":[80],"treatments":[81],"targeting":[82],"system,":[85],"GLP-1":[88,144,159],"receptor":[89,160],"agonists,":[90],"offer":[91],"potential":[93],"to":[94,164],"address":[95,165],"(one":[98],"underlying":[100],"pathogenic":[101],"mechanisms":[102],"type":[104],"2":[105],"diabetes),":[106],"well":[108],"resulting":[111],"hyperglycaemia.":[112],"Initial":[113],"evidence":[114],"now":[115],"suggests":[116],"that":[117],"incretins":[118],"could":[119,162],"beneficial":[121],"effects":[122,133,141],"on":[123,134],"system":[129],"through":[130,143],"both":[131],"indirect":[132],"reduction":[136],"hyperglycaemia":[138],"direct":[140],"mediated":[142],"receptor-dependent":[145],"-independent":[147],"mechanisms.":[148],"If":[149],"these":[150],"initial":[151],"findings":[152],"are":[153],"confirmed":[154],"larger":[156],"clinical":[157],"trials,":[158],"antagonists":[161],"help":[163],"faced":[170],"by":[171],"patients":[172]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2008337869","counts_by_year":[{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":2},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":5},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
